Journal of Clinical & Experimental OncologyISSN: 2324-9110

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

Article Review on Anthracyclines and Anthracycline-induced Cardiotoxicity

Cancer is rapidly growing to be one of the leading causes of death globally. As of 2018, there were more than 17 million new cancer cases, with a half fold death toll accounting for 9.5 million lives worldwide. Ideally, the statistics highlight an excepted projection in the global burden, leading to 27.5 million new cancer cases [1]. Despite the adversity of these statistics, recent advancement in the diagnosis and screening of malignant cancerous tumours has significantly lowered cancer
mortalities, leading to a 50% and 75% survival rate among adults and children, respectively. However, this success has led to the recognition of other cancer-treatment related toxicities and a similar need for the identification of early prevention and mitigation approaches.

Special Features

Full Text

View

Track Your Manuscript

Scheduled supplementary issues

View More »

Media Partners

Associations

GET THE APP